{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:46:49Z","timestamp":1759333609192},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s10165-008-0088-2","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T07:14:09Z","timestamp":1213254849000},"page":"442-446","source":"Crossref","is-referenced-by-count":2,"title":["Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"18","author":[{"given":"Shigeko","family":"Inokuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemasa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,13]]},"reference":[{"key":"88_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(04)15527-X","volume":"363","author":"J McCurry","year":"2004","unstructured":"McCurry J. Japan deaths spark concerns over arthritis drug. Lancet. 2004;363:461.","journal-title":"Lancet"},{"key":"88_CR2","first-page":"891","volume":"52","author":"Y Ichikawa","year":"2003","unstructured":"Ichikawa Y, Kamatani N, Goto M, Kondo H, Saito T, Suzuki Y, et al. Phase II dose ranging study of leflunomide in Japan. J New Rem & Clin. 2003;52:891\u2013931.","journal-title":"J New Rem & Clin"},{"key":"88_CR3","unstructured":"Appended document of Arava\u00ae (in Japanese). Sanofi-Aventis Japan; 2006 revised."},{"key":"88_CR4","first-page":"876","volume":"52","author":"H Momo","year":"2003","unstructured":"Momo H, Suzuki H, Mitsuhashi H, Urata M, Nitta Y, Yasuda K. Evaluation of pharmacokinetics and safety of leflunomide (HWA486) in healthy adult men (author\u2019s translation). J New Rem & Clin. 2003;52:876\u201390.","journal-title":"J New Rem & Clin"},{"key":"88_CR5","first-page":"85","volume":"52","author":"K Yasuda","year":"2003","unstructured":"Yasuda K, Momo H, Suzuki H, Urata M, Muraki S, Mitsuhashi H. Study of removal therapy of active metabolite (A771726) of leflunomide (HWA486) by colestyramine (author\u2019s translation). J New Rem & Clin. 2003;52:85\u201394.","journal-title":"J New Rem & Clin"},{"key":"88_CR6","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","volume":"159","author":"V Strand","year":"1999","unstructured":"Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med. 1999;159:2542\u201350.","journal-title":"Arch Intern Med"},{"key":"88_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","volume":"353","author":"JS Smolen","year":"1999","unstructured":"Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet. 1999;353:259\u201366.","journal-title":"Lancet"},{"issue":"Suppl","key":"88_CR8","first-page":"27","volume":"53","author":"B Rozman","year":"1998","unstructured":"Rozman B. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators\u2019 Group. J Rheumatol.. 1998;53 (Suppl):27.","journal-title":"J Rheumatol."},{"key":"88_CR9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2165\/00003495-199958060-00010","volume":"58","author":"A Prakash","year":"1999","unstructured":"Prakash A, Jarvis B. Leflunomide\u2014a review of its use in active rheumatoid arthritis. Drugs. 1999;58:1137\u201364.","journal-title":"Drugs"},{"issue":"Suppl","key":"88_CR10","first-page":"99","volume":"17","author":"T Sawada","year":"2007","unstructured":"Sawada T, Inokuma S, Sato T, Sagawa A, Matsuda T, Takemura T, et al. Leflunomide-induced lung diseases: overview of its occurrence, and identification of risk factors. Mod Rheumatol. 2007;17(Suppl):99.","journal-title":"Mod Rheumatol"},{"issue":"Suppl","key":"88_CR11","first-page":"100","volume":"17","author":"T Sato","year":"2007","unstructured":"Sato T, Inokuma S, Sagawa A, Matsuda T, Ohtsuka T, Saeki Y, et al. Analysis of rheumatoid arthritis patients of died of and recovered from leflunomide-induced interstitial pneumonia. Mod Rheumatol. 2007;17(Suppl):100.","journal-title":"Mod Rheumatol"},{"key":"88_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2169\/internalmedicine.45.1455","volume":"45","author":"Y Hirabayashi","year":"2006","unstructured":"Hirabayashi Y, Shimizu H, Kobayashi N, Kudo K. Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis. Intern Med. 2006;45:689\u201391.","journal-title":"Intern Med"},{"key":"88_CR13","unstructured":"Study Group of the Ministry of Health, Labour and Welfare. Therapeutic manual of rheumatoid arthritis (revised). Diagnostic manual and evidence-based treatment guidelines. Jpn Rheum Found; 2004."},{"key":"88_CR14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/ard.2005.045211","volume":"65","author":"S Inokuma","year":"2006","unstructured":"Inokuma S, Kono H, Kohno Y, Hiramatsu K, Ito K, Shiratori K, et al. Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease. Ann Rheum Dis. 2006;65:1113\u20134.","journal-title":"Ann Rheum Dis"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-008-0088-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:27:02Z","timestamp":1646843222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-008-0088-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,13]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1007\/s10165-008-0088-2","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,13]]}}}